MD
MADRIGAL PHARMACEUTICALS, INC.
Nasdaq : MDGLHealthcare · Pharmaceutical Preparations
Mkt Cap$12.28BShares Out23.10M30d Avg Vol12.74MShort Int—Short Float—IPOFeb 6, 2007
▼-1.32%
$3.00
–
| Form | Description | Filed |
|---|---|---|
| 144 | Notice of Proposed Sale of Securities | Jun 30, 2026 |
| 424B5 | Prospectus Supplement | Jun 30, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 24, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 24, 2026 |
| 144 | Notice of Proposed Sale of Securities | Jun 19, 2026 |
| SD | Specialized Disclosure Report | Jun 19, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 19, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 19, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 13, 2026 |
| 8-K | 2.02 | Jun 13, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 13, 2026 |
| 144 | Notice of Proposed Sale of Securities | Jun 10, 2026 |
| N-PX | Proxy Voting Record | Jun 5, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 5, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 4, 2026 |
| 4/A | Statement of Changes in Beneficial Ownership (Amended)4 | May 30, 2026 |
| 8-K | 8.01,9.01 | May 30, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 24, 2026 |
| DEF 14A | Proxy Statement | May 23, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 21, 2026 |
| 144 | Notice of Proposed Sale of Securities | May 21, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 21, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 21, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 21, 2026 |
| 144 | Notice of Proposed Sale of Securities | May 21, 2026 |
1-25 of 210 filings
…